News
CELZ
4.395
-3.41%
-0.155
Weekly Report: what happened at CELZ last week (0422-0426)?
Weekly Report · 6d ago
Weekly Report: what happened at CELZ last week (0415-0419)?
Weekly Report · 04/22 10:28
Weekly Report: what happened at CELZ last week (0408-0412)?
Weekly Report · 04/15 10:22
Weekly Report: what happened at CELZ last week (0401-0405)?
Weekly Report · 04/08 10:25
Weekly Report: what happened at CELZ last week (0325-0329)?
Weekly Report · 04/01 10:24
Creative Medical Technology Holdings Inc reports results for the quarter ended in December - Earnings Summary
Creative Medical Technology Holdings Inc reports results for the quarter ended in December. The company reported a quarterly adjusted loss of $1.19 per share. Revenue fell 84.2% to $3.00 thousand from a year ago. Shares had risen by 12.6% this quarter.
Reuters · 03/25 21:01
Weekly Report: what happened at CELZ last week (0318-0322)?
Weekly Report · 03/25 10:26
Creative Medical Technology Holdings Inc <CELZ.OQ> expected to post a loss of $1.13 a share - Earnings Preview
Creative Medical Technology Holdings Inc expected to post a loss of $1.13 a share - Earnings Preview. The one available analyst rating on the shares is "buy" for the company. The company is expected to show a fall in quarterly revenue when it reports results.
Reuters · 03/22 20:17
Weekly Report: what happened at CELZ last week (0311-0315)?
Weekly Report · 03/18 10:25
Weekly Report: what happened at CELZ last week (0304-0308)?
Weekly Report · 03/11 10:23
BREA, MSAI and APM among pre-market losers
On the Move BREA, MSAI and APM among pre-market losers. Amylyx Pharmaceuticals (AMLX) falls 81% as late-stage ALS trial for Relyvrio fails. Petroleo Brasileiro (PBR.A) is one of the day's biggest losers.
Seeking Alpha · 03/08 13:40
12 Health Care Stocks Moving In Thursday's After-Market Session
Ainos (NASDAQ:AIMD) shares moved upwards by 100.0% to $2.24 during Thursday's after-market session. Unicycive Therapeutics stock rose 8.66% during the day. Talphera and Akili also moved upwards. Losers include Biofrontera and Creative Medical Tech.
Benzinga · 03/07 21:31
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
HighPeak Energy, Inc. Shares fell 15.3% to $13.49 on Thursday. The company reported worse-than-expected fourth-quarter revenue results. Lytus Technologies Holdings PTV. Ltd. Shares jumped 404% in the mid-day session.
Benzinga · 03/07 18:35
Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?
Creative Medical Technology Holdings Inc (NASDAQ:CELZ) secured FDA authorization for an expanded access therapy using CELZ-201 to prevent Type 1 diabetes. The therapy uses a cell-based program to manage abnormal glucose tolerance and prevent T1D onset in high-risk individuals.
Benzinga · 03/07 18:16
12 Health Care Stocks Moving In Thursday's Intraday Session
Psyence Biomedical stock moved upwards by 35.3% to $1.38 during Thursday's regular session. HeartBeam stock rose 26.53% and Ocean Biomedical shares increased by 24.4% during the session. Losers Avid Bioservices stock fell 31.2% and Aptorum Gr stock decreased by 31.3%.
Benzinga · 03/07 17:31
Creative Medical stock rallies for second day on FDA updates
Creative Medical stock rallies for second day on FDA updates for its cell therapy candidates. Shares of Creative Medical Technology recently sold for $7.08, up 50% from the prior close. The stock closed 15% higher on Wednesday on positive FDA updates to the company's two cell therapies.
Seeking Alpha · 03/07 17:13
Creative Medical (CELZ) Up on Orphan Drug Tag for CELZ-101
NASDAQ · 03/07 16:04
Creative Medical Shares Rise 37% After FDA Authorization for CELZ-201
Creative Medical Technology Holdings shares were up 37% at $6.50. The company said it received FDA authorization for an expanded access therapy using CELZ-201. The therapy uses a cell-based program to potentially prevent Type 1 Diabetes Mellitus in high-risk individuals. The stock hit its 52-week low of $3.93.
Dow Jones · 03/07 15:14
Viking Therapeutics, Creative Medical Technology, Aptorum Group among healthcare movers
Viking Therapeutics, Creative Medical Technology, Aptorum Group among healthcare movers in SA. S&P 500 Health Care Sector +0.22% to 1702.66. Pharmaceuticals, Biotechnology & Life Science contributes 58% to the index.
Seeking Alpha · 03/07 15:01
Creative Medical Technology Skyrockets on Word of New Diabetes Medication
Creative Medical Technology Holdings, Inc. Shares nearly doubled in price Thursday. The company has secured FDA authorization for an expanded access therapy using CELZ-201 to potentially prevent Type 1 Diabetes Mellitus (T1D) The company's shares climbed $3.88, or 81.5%, to $8.64.
Barchart · 03/07 08:50
More
Webull provides a variety of real-time CELZ stock news. You can receive the latest news about Creative Med Technology Hldgs through multiple platforms. This information may help you make smarter investment decisions.
About CELZ
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.